Shobana Balasingam

In collaboration with the @novonordiskfond and @gatesfoundation, we’re funding teams globally to address the barriers to early antibiotic discovery. ✅ Eligibility: teams from academia or industry 💡 Duration: up to three years 💰 Level: up to $5 million gcgh.grandchallenges.org/challenge/inno…

Does your team have verifiable experience facilitating scientific meetings? @wellcometrust is seeking a facilitator for the Pathogen Variants Network meeting in Bangkok, Thailand (Sept 2025). AND a science writer to prepare a meeting report. Details: cms.wellcome.org/sites/default/…

“But the WHO’s head, Dr ⁦@DrTedros⁩ Adhanom Ghebreyesus, has repeatedly called on China to adequately investigate and rapidly disclose information about the origins of the Covid-19 virus that emerged in Wuhan five years ago.” ⁦@GordonBrown⁩ theguardian.com/commentisfree/…

Well-deserved @Egesa_Moses. Here's to continued progress and hope for a brighter future in combating Bilharzia

Human challenge trials have the power to rapidly accelerate the development of much-needed vaccines and treatments. Dr Kondwani Jambo (@kjambo), an expert on the topic at @MLW_Programme, explains more ⤵️

The #HICVacAnnualMeeting2024 may be at full in-person capacity, but you can still be part! Register to join us virtually: forms.office.com/e/Vf2a6QZHCx

Non-typhoidal Salmonella (NTS) causes a significant global health burden, particularly in sub-Saharan Africa. Here's how a new @imperialcollege human challenge study could pave the way to addressing this challenge. [1/6] 🧵

How is science stepping up to tackle emerging health challenges swiftly and effectively? 🧪🔬 Join our @ImperialSPH and @ImperialInfect researchers at @ImperialSci's panel discussion on vaccine development and deployment! 🗓️ 26 Sept ⏰ 16:10–17:10 BST 🔗 imperial.ac.uk/events/178102/…

Are you interested in advancing COVID-19 vaccine research? We're currently recruiting volunteers to take part in a human challenge study at @VaccineTrials to help us better understand the disease. Find out more 👇 jenner.ac.uk/volunteer/recr…

17th Asian Conference on Diarrhoeal Disease and Nutrition 8-10th Dec 2024, Kathmandu details and registration 👇

@wellcometrust would like to understand what TB biomarkers are out there, and what it would take to move them to clinical evaluation. If this is something you or your team can do, take a look and express interest by 5th July 2024 wellcome.org/sites/default/…

Join a Wellcome advisory committee. wellcome.org//grant-funding…

Register now for the Controlled Human Infection Studies virtual engagement workshop. 🗓️ 29 – 30 May 2024 Registration links: Day 1: rb.gy/syx1gn Day 2: rb.gy/aw4mst

The challenges of challenge studies An example from COVID 👇nature.com/articles/d4158…

Mosquito-borne diseases spreading in Europe due to climate crisis, says expert theguardian.com/environment/20…

Paving the way to virus-blocking #vaccines? 🦠🚫 We're proud to be leading a new global human challenge consortium to develop next-generation vaccines for viruses like #COVID19. #WorldImmunisationWeek #WIW2024 @ImperialInfect @ChrisChiuLab @CEPIvaccines imperial.ac.uk/news/251961/gl…

Looking for infectious disease funding? We’re funding teams to generate data to develop effective interventions for dengue and Zika through researching their spread, immunity and clinical outcomes. Here’s what you need to know before you apply ⤵️ wellc.me/4ag5vm6

The Ethics of Human Challenge Studies @Shoba35 Balasingam, @JerryMenikoff, @PeterSinger, and Jake Eberts co-organised with the NCID, Singapore, on Monday 8 April 2024 #ResearchEthics @NUS_CBmE @1DaySooner @WellcomeTrust

The HIC-Vac Annual Meeting 2022 report has now been published and is available here: pubmed.ncbi.nlm.nih.gov/38020312/.

@NatureMicrobiol asked me to write a personal piece on 25yrs of #iNTS vaccine research. What does sustainable success look like, in the face of huge inequities? I reflected a bit on humility in facing Global Health challenges. rdcu.be/dzKr0 (free text access link)